Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Ellington Residential Mortgage REIT Announces Public Offering of Common Shares
-
Ignyta Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Gladstone Investment (GAIN) Prices 2.1M Common Stock Offering at $9.38/Share
-
Gladstone Investment Corporation Prices Common Stock Offering
-
Spark Energy (SPKE) PT Raised to $34 at Ladenburg Thalmann on '1Q17 Results, 2017 Guidance Reaffirmed, Acquisition Announced'
-
Form 10-Q LADENBURG THALMANN FINAN For: Mar 31
-
Ladenburg Thalmann Reports First Quarter 2017 Financial Results
-
Gladstone Investment (GAIN) Plans Common Stock Offering
-
Gladstone Investment Corporation Announces Common Stock Offering
-
Ladenburg Thalmann Launches Ladenburg Thalmann Annuity Insurance Services
-
Eagle Point Credit Company Inc. Announces Exercise of Overallotment Option in Offering of Common Stock
-
Dextera Surgical Reports Fiscal 2017 Third Quarter Financial Results
-
SITO Mobile Issues Letter To Stockholders
-
Ladenburg Thalmann Downgrades Spirit Realty Capital (SRC) to Neutral
-
Ignyta (RXDX) Prices 12.5M Common Stock Offering at $6.15/Share
-
SITO Mobile (SITO) PT Raised to $7.80 at Ladenburg Thalmann, "Impressive Revenue Guidance for Q2"
-
Ignyta Announces Pricing of Public Offering of Common Stock
-
Ladenburg Thalmann Starts EnteroMedics (ETRM) at Buy
-
Ladenburg Thalmann Downgrades Intra-Cellular Therapies (ITCI) to Neutral
-
Form EFFECT LADENBURG THALMANN FINAN
-
Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral, "Q1 Shows Modest Growth Glimmer with Plenty of Work Ahead"
-
ChromaDex Announces Strategic Investment Led by Mr. Li Ka-shing
-
Gramercy Property Trust Announces Closing of Public Offering of 10,350,000 Common Shares
-
Sunshine Heart Announces Closing of $9.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Sunshine Heart Announces Closing of $9.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Dextera Surgical Announces Preliminary Fiscal 2017 Third Quarter Financial Highlights
-
Ladenburg Thalmann Sends Annual Letter to Shareholders
-
Form S-3/A LADENBURG THALMANN FINAN
-
Form DEF 14A LADENBURG THALMANN FINAN For: May 24
-
Gramercy Property Trust (GPT) Prices 9M Share Offering at $27.60/Sh
-
Gramercy Property Trust Announces Pricing of Public Offering of 9,000,000 Common Shares
-
Whitestone REIT Announces Pricing of Public Offering of Common Shares
-
Pre-Open Movers 04/20: (IMNP) (SCSS) (KCG) Higher; (PLXS) (WR) (PM) Lower (more...)
-
Eagle Point Credit (ECC) Prices 1.35M Share Offering at $19.50/Sh
-
Eagle Point Credit Company Inc. Prices Offering of Common Stock
-
Ring Energy, Inc. (REI) PT Raised to $17 at Ladenburg Thalmann
-
After-Hours Stock Movers 04/19: (SCSS) (SLM) (CSX) Higher; (PLXS) (WR) (EBAY) Lower (more...)
-
Whitestone REIT (WSR) Commences 8.1M Share Common Stock Offering
-
Whitestone REIT Announces Proposed Offering of Common Shares
-
Eagle Point Credit (ECC) Commences 1.25M Share Common Stock Offering
-
Eagle Point Credit Company Inc. Announces Offering of Common Stock
-
Sunshine Heart (SSH) Prices $8M Share Offering at $1 per Class A Unit, $1000 per Class B Unit
-
Sunshine Heart Announces Pricing of $8.0 Million Underwritten Public Offering
-
Nivalis Therapeutics (NVLS) to Merge with Alpine Immune Sciences in All-Stock Deal
-
Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc. Agree to Combine
-
Ladenburg Thalmann Starts Bellerophon Therapeutics (BLPH) at Buy
-
Form S-3/A LADENBURG THALMANN FINAN
-
Ladenburg Thalmann Starts Reata Pharmaceuticals (RETA) at Buy
-
Catalyst Biosciences Announces Closing of a $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
TICC Capital Corp. Completes Public Offering of $64,370,225 6.50% Notes Due 2024

